vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $65.9M, roughly 1.1× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs -14.6%, a 32.1% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs 4.1%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs 4.0%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

EOLS vs OSPN — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.1× larger
EOLS
$73.1M
$65.9M
OSPN
Growing faster (revenue YoY)
EOLS
EOLS
+2.7% gap
EOLS
6.7%
4.1%
OSPN
Higher net margin
OSPN
OSPN
32.1% more per $
OSPN
17.5%
-14.6%
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
4.6%
4.0%
OSPN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EOLS
EOLS
OSPN
OSPN
Revenue
$73.1M
$65.9M
Net Profit
$-10.7M
$11.6M
Gross Margin
66.9%
73.6%
Operating Margin
23.8%
22.5%
Net Margin
-14.6%
17.5%
Revenue YoY
6.7%
4.1%
Net Profit YoY
EPS (diluted)
$-0.16
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
OSPN
OSPN
Q1 26
$73.1M
$65.9M
Q4 25
$90.3M
$62.9M
Q3 25
$69.0M
$57.1M
Q2 25
$69.4M
$59.8M
Q1 25
$68.5M
$63.4M
Q4 24
$78.9M
$61.2M
Q3 24
$61.1M
$56.2M
Q2 24
$66.9M
$60.9M
Net Profit
EOLS
EOLS
OSPN
OSPN
Q1 26
$-10.7M
$11.6M
Q4 25
$130.0K
$43.5M
Q3 25
$-15.7M
$6.5M
Q2 25
$-17.1M
$8.3M
Q1 25
$-18.9M
$14.5M
Q4 24
$-6.8M
$28.8M
Q3 24
$-19.2M
$8.3M
Q2 24
$-11.3M
$6.6M
Gross Margin
EOLS
EOLS
OSPN
OSPN
Q1 26
66.9%
73.6%
Q4 25
65.7%
73.6%
Q3 25
66.5%
73.6%
Q2 25
65.3%
73.5%
Q1 25
68.1%
74.3%
Q4 24
66.7%
74.0%
Q3 24
68.9%
73.9%
Q2 24
70.3%
66.2%
Operating Margin
EOLS
EOLS
OSPN
OSPN
Q1 26
23.8%
22.5%
Q4 25
4.7%
19.9%
Q3 25
-16.7%
14.4%
Q2 25
-14.7%
17.6%
Q1 25
-22.1%
27.1%
Q4 24
-2.9%
19.3%
Q3 24
-25.3%
20.0%
Q2 24
-11.5%
12.5%
Net Margin
EOLS
EOLS
OSPN
OSPN
Q1 26
-14.6%
17.5%
Q4 25
0.1%
69.2%
Q3 25
-22.8%
11.4%
Q2 25
-24.7%
13.9%
Q1 25
-27.6%
22.9%
Q4 24
-8.6%
47.1%
Q3 24
-31.4%
14.7%
Q2 24
-17.0%
10.8%
EPS (diluted)
EOLS
EOLS
OSPN
OSPN
Q1 26
$-0.16
$0.39
Q4 25
$0.01
$1.13
Q3 25
$-0.24
$0.17
Q2 25
$-0.27
$0.21
Q1 25
$-0.30
$0.37
Q4 24
$-0.11
$0.73
Q3 24
$-0.30
$0.21
Q2 24
$-0.18
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$49.8M
$49.8M
Total DebtLower is stronger
$156.4M
Stockholders' EquityBook value
$272.0M
Total Assets
$220.6M
$383.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
OSPN
OSPN
Q1 26
$49.8M
$49.8M
Q4 25
$53.8M
$70.5M
Q3 25
$43.5M
$85.6M
Q2 25
$61.7M
$92.9M
Q1 25
$67.9M
$105.2M
Q4 24
$87.0M
$83.2M
Q3 24
$85.0M
$77.5M
Q2 24
$93.7M
$63.8M
Total Debt
EOLS
EOLS
OSPN
OSPN
Q1 26
$156.4M
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
OSPN
OSPN
Q1 26
$272.0M
Q4 25
$-23.1M
$271.8M
Q3 25
$-28.8M
$238.3M
Q2 25
$-18.7M
$242.5M
Q1 25
$-6.6M
$231.1M
Q4 24
$5.5M
$212.5M
Q3 24
$5.9M
$194.6M
Q2 24
$19.3M
$178.6M
Total Assets
EOLS
EOLS
OSPN
OSPN
Q1 26
$220.6M
$383.1M
Q4 25
$225.9M
$397.7M
Q3 25
$219.0M
$343.5M
Q2 25
$228.8M
$357.1M
Q1 25
$213.4M
$333.8M
Q4 24
$232.6M
$338.7M
Q3 24
$229.6M
$289.3M
Q2 24
$233.8M
$286.9M
Debt / Equity
EOLS
EOLS
OSPN
OSPN
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
OSPN
OSPN
Operating Cash FlowLast quarter
$28.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
OSPN
OSPN
Q1 26
$28.2M
Q4 25
$12.8M
$12.6M
Q3 25
$-14.7M
$11.3M
Q2 25
$-24.8M
$6.2M
Q1 25
$-15.6M
$29.4M
Q4 24
$4.8M
$12.4M
Q3 24
$-5.7M
$14.0M
Q2 24
$-6.5M
$2.3M
Free Cash Flow
EOLS
EOLS
OSPN
OSPN
Q1 26
Q4 25
$11.3M
$9.6M
Q3 25
$-15.6M
$8.8M
Q2 25
$-25.5M
$4.4M
Q1 25
$-16.0M
$27.7M
Q4 24
$4.4M
$10.5M
Q3 24
$-6.0M
$12.0M
Q2 24
$-6.9M
$26.0K
FCF Margin
EOLS
EOLS
OSPN
OSPN
Q1 26
Q4 25
12.6%
15.3%
Q3 25
-22.7%
15.4%
Q2 25
-36.7%
7.3%
Q1 25
-23.3%
43.8%
Q4 24
5.5%
17.1%
Q3 24
-9.9%
21.4%
Q2 24
-10.4%
0.0%
Capex Intensity
EOLS
EOLS
OSPN
OSPN
Q1 26
Q4 25
1.6%
4.7%
Q3 25
1.4%
4.4%
Q2 25
1.0%
3.1%
Q1 25
0.5%
2.6%
Q4 24
0.6%
3.2%
Q3 24
0.5%
3.5%
Q2 24
0.7%
3.7%
Cash Conversion
EOLS
EOLS
OSPN
OSPN
Q1 26
2.44×
Q4 25
98.67×
0.29×
Q3 25
1.74×
Q2 25
0.75×
Q1 25
2.02×
Q4 24
0.43×
Q3 24
1.69×
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

Related Comparisons